Roflumilast
NDC 59746-801, roflumilast, tablet, from Jubilant Cadista Pharmaceuticals Inc..
- Product NDC
- 59746-801
- Status
- Listed
- Labeler
- Jubilant Cadista Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208236
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59746-801 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROFLUMILAST250 ug/1
Pharmacologic classes
Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59746-801-70 | 59746080170 | 28 TABLET in 1 BLISTER PACK (59746-801-70) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/aaa81c1b-f63d-4e61-8bfa-9d42d92043c7NADAC price for package 59746080170
GET /v1/drugs/nadac/59746080170
Use it
Look up 59746-801 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59746-801 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59746-801. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.